Adherex Technologies (FENC)
(Real Time Quote from BATS)
$5.27 USD
-0.02 (-0.38%)
Updated Sep 20, 2024 02:58 PM ET
5-Strong Sell of 5 5
D Value A Growth D Momentum B VGM
Brokerage Reports
0 items in cart
Adherex Technologies Inc. [FENC]
Reports for Purchase
Showing records 21 - 40 ( 109 total )
Company: Adherex Technologies Inc.
Industry: Medical - Drugs
PEDMARK Commercialization on Track; 2022 Financials; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Adherex Technologies Inc.
Industry: Medical - Drugs
Company: Adherex Technologies Inc.
Industry: Medical - Drugs
Clinical Practice Guidelines Recommend PEDMARK; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Adherex Technologies Inc.
Industry: Medical - Drugs
Company: Adherex Technologies Inc.
Industry: Medical - Drugs
Company: Adherex Technologies Inc.
Industry: Medical - Drugs
PEDMARK U.S. Launch in Process; Raising PT to $18
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Adherex Technologies Inc.
Industry: Medical - Drugs
Company: Adherex Technologies Inc.
Industry: Medical - Drugs
Company: Adherex Technologies Inc.
Industry: Medical - Drugs
Company: Adherex Technologies Inc.
Industry: Medical - Drugs
Company: Adherex Technologies Inc.
Industry: Medical - Drugs
HEALTHCARE- The Week Ahead in Life Sciences
Provider: Wedbush Securities Inc.
Analyst: Research Department
Company: Adherex Technologies Inc.
Industry: Medical - Drugs
Company: Adherex Technologies Inc.
Industry: Medical - Drugs
Company: Adherex Technologies Inc.
Industry: Medical - Drugs
Company: Adherex Technologies Inc.
Industry: Medical - Drugs
Company: Adherex Technologies Inc.
Industry: Medical - Drugs
The Fox Tries Again in ''22, Can It Reach the Prize?
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D